CatalystPit

ALECAlector, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.85 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$206.57M
CountryUSA
RECENT INSIDER TRADES
  • 2026-09-04 · Wong-Sarad Grace (Principal Accounting Officer) · SELL
  • 2026-09-04 · Rosenthal Arnon (Chief Executive Officer) · SELL
  • 2026-09-04 · Berkley Neil Lindsay (CFO & Chief Business Officer) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders153
Shares held108,584,871
Value$229.31M
Percent of shares outstanding97.25%
As of quarter end2026-06-30
RECENT NEWS
  • Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
  • Genentech licenses Alector blood-brain barrier technology for $1.27B
  • Alector surges on licensing agreement with Genentech
  • Why is Alector stock surging today?
  • Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS